Long-term functional prognosis and related factors of spinal cord stimulation in patients with disorders of consciousness.

Yang Y
He Q
Xia X
Dang Y
Chen X
He J
Zhao J
Scientific Abstract

The treatment of patients with disorders of consciousness (DoC) remains a challenging issue, and spinal cord stimulation (SCS) has been reported to be a promising treatment for DoC in some studies.

This study explores the efficiency of SCS in treating patients with DoC at different consciousness levels, including the vegetative state/unresponsive wakefulness syndrome (VS/UWS) and the minimally conscious state (MCS) and summarizes and analyzes the long-term effect and related factors of SCS in patients with DoC.

An overall positive outcome was reached in 35 of 110 patients (31.8%). Among patients with positive outcomes, the MCS group improved 45.53% more than VS/UWS group, and this difference was statistically significant. In terms of the recommendation standard, positive outcomes occurred in 33 patients (94.3%) in the highly recommended group and 2 patients (5.7%) in the weakly recommended group (p < 0.001). After adjustment for potential covariables, young age (age ≤ 19 years old) (p = 0.045) and MCS (p < 0.001) were significantly correlated with positive outcome. A nomogram based on age, state of consciousness, and pathogeny showed good predictive performance, with a c-index of 0.794. The Hosmer-Lemeshow goodness-of-fit test showed that the model was well calibrated (χ  = 3.846, p = 0.871).

SCS is one of the most feasible treatments for patients with DoC, especially for patients with MCS. Younger age is significantly associated with better outcomes and could therefore serve as a basis for preoperative screening. However, more evidence-based randomized controlled trials are needed to confirm the efficacy of the treatment.

Citation

2022. CNS Neurosci Ther, 28(8):1249-1258.

DOI
10.1111/cns.13870
Related Content
Publication
Author
Koolschijn RS
Clarke WT
Ip IB
Emir UE

2023. Neuroimage, 276:120194.

Publication
Author
Wang HL
Cheng W
Rolls ET
Dai F
Gong W
Du J
Zhang WN
Wang S
Liu F
Wang J
Feng J
2020. Neurology, 95(11):e1445-e1460.